BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29793312)

  • 21. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.
    San Jose-Eneriz E; Agirre X; Rodríguez-Otero P; Prosper F
    Epigenomics; 2013; 5(5):525-38. PubMed ID: 24059799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.
    Wang CX; Wang X; Liu HB; Zhou ZH
    Asian Pac J Cancer Prev; 2014; 15(1):355-62. PubMed ID: 24528056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
    Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
    Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis.
    Ranjbar R; Karimian A; Aghaie Fard A; Tourani M; Majidinia M; Jadidi-Niaragh F; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3216-3230. PubMed ID: 29384211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
    Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
    Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Artieda P; Cordeu L; Lahortiga I; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Int J Cancer; 2006 Apr; 118(8):1945-53. PubMed ID: 16287063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics.
    Fathi E; Farahzadi R; Montazersaheb S; Bagheri Y
    Curr Gene Ther; 2021; 21(1):60-71. PubMed ID: 33183201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
    Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
    J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Abnormal methylation of p16/CDKN2A AND p14/ARF genes GpG Islands in non-small cell lung cancer and in acute lymphoblastic leukemia].
    Zemliakova VV; Strel'nikov VV; Zborovskaia IB; Balukova OV; Maĭorova OA; Vasil'ev EV; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2004; 38(6):966-72. PubMed ID: 15612580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
    Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
    Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
    Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
    Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
    Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
    Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.
    Vasconcelos GM; Christensen BC; Houseman EA; Xiao J; Marsit CJ; Wiencke JK; Zheng S; Karagas MR; Nelson HH; Wrensch MR; Kelsey KT; Pombo-de-Oliveira MS; Wiemels JL
    Epigenetics; 2011 Dec; 6(12):1436-43. PubMed ID: 22139573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
    Gabriel AS; Lafta FM; Schwalbe EC; Nakjang S; Cockell SJ; Iliasova A; Enshaei A; Schwab C; Rand V; Clifford SC; Kinsey SE; Mitchell CD; Vora A; Harrison CJ; Moorman AV; Strathdee G
    Epigenetics; 2015; 10(8):717-26. PubMed ID: 26237075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.
    Hütter G; Kaiser M; Neumann M; Mossner M; Nowak D; Baldus CD; Gökbuget N; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2011 May; 35(5):614-9. PubMed ID: 21156323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic analysis of childhood acute lymphoblastic leukemia.
    Dunwell TL; Hesson LB; Pavlova T; Zabarovska V; Kashuba V; Catchpoole D; Chiaramonte R; Brini AT; Griffiths M; Maher ER; Zabarovsky E; Latif F
    Epigenetics; 2009 Apr; 4(3):185-93. PubMed ID: 19430199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.